eli lilly retatrutide phase 3 trial Shows 28% Weight Loss in 80 Weeks Starting Phase 3b Clinical Trial

But because my clients considering Mounjaro and Wegovy were asking questions I couldnt answer

Heres where things get tricky (and a little frustrating)

Retatrutide is a next-generation synthetic peptide that activates three hormone receptors at once: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and the glucagon receptor

In-vivo electrocardiographic (ECG) recording Mice were placed under isoflurane anesthesia (1.5%2%) on a heated pad (body temperature maintained at 37C, measured by the rectal probe)

The same patented 300mg dose of Niagen that is clinically proven to raise NAD+ levels by over 50% in as little as two weeks, now in a flavorless powder you throw in your gym bag, jersey pocket, carry-on, or desk drawer